000 | 01959 a2200529 4500 | ||
---|---|---|---|
005 | 20250514230615.0 | ||
264 | 0 | _c20050712 | |
008 | 200507s 0 0 eng d | ||
022 | _a1072-7515 | ||
024 | 7 |
_a10.1016/j.jamcollsurg.2005.01.024 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFernandez, Felix G | |
245 | 0 | 0 |
_aEffect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. _h[electronic resource] |
260 |
_bJournal of the American College of Surgeons _cJun 2005 |
||
300 |
_a845-53 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aCamptothecin _xadministration & dosage |
650 | 0 | 4 |
_aChemotherapy, Adjuvant _xadverse effects |
650 | 0 | 4 |
_aColorectal Neoplasms _xpathology |
650 | 0 | 4 |
_aFatty Liver _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
650 | 0 | 4 | _aHepatectomy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIrinotecan |
650 | 0 | 4 |
_aLiver Neoplasms _xsecondary |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
650 | 0 | 4 | _aOxaliplatin |
650 | 0 | 4 | _aPreoperative Care |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTopoisomerase I Inhibitors |
700 | 1 | _aRitter, John | |
700 | 1 | _aGoodwin, J Wendell | |
700 | 1 | _aLinehan, David C | |
700 | 1 | _aHawkins, William G | |
700 | 1 | _aStrasberg, Steven M | |
773 | 0 |
_tJournal of the American College of Surgeons _gvol. 200 _gno. 6 _gp. 845-53 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jamcollsurg.2005.01.024 _zAvailable from publisher's website |
999 |
_c15583460 _d15583460 |